Skip to main content

Macular telangiectasia with bilateral obliterated capillaries: a case report



We report an otherwise healthy adult with macular telangiectasia with aneurysms, ischemia, and obliterated capillaries in both eyes.


This is a case report with a brief literature review.

Case presentation

A 58-year-old Iranian woman presented with a gradual decrease in vision, with recent deterioration. Past medical history was unremarkable, and best-corrected visual acuity was 3/10 in both eyes. Multimodal imaging including fundus photo, fluorescein angiography, optical coherence tomography, and optical coherence tomography angiography was carried out. In macula of both eyes, parafoveal telangiectasia, occluded vessels, capillary dropouts, and aneurysms were observed. While there were a dense circinate exudation and edema in the macula of the right eye and a thin and disorganized inner retinal layer in the left eye, the outer retina was intact in both eyes. En face optical coherence tomography angiography revealed capillary blunting and rarefaction in both superficial and deep capillary plexuses of retina.


Our case most probably represents a case of type 3 macular telangiectasia in the absence of any systemic association.

Peer Review reports


The term “macular telangiectasia” refers to the dilation of the capillary network at the parafoveal region due to congenital or developmental etiologies. Idiopathic macular telangiectasia (IMT or MacTel), first described by Gass and Oyakawa, as incompetent telangiectatic capillaries supplying the juxtafoveal area [1], was later classified by Gass and Blodi in 1993 into three types. MacTel type 1 is a developmental condition that is typically characterized by unilateral aneurysms and telangiectasia located in the temporal half of the macula, accompanied by exudation and cystoid macular edema (CME). MacTel type 2 is an acquired condition and is typically bilateral, and nonexudative and aneurysmal changes are not apparent. Among its distinctive features are superficial crystalline deposits, right-angle venules, and intraretinal pigment migration. The third type is an acquired bilateral occlusive macular telangiectasia with progressive vision loss. It has been poorly understood, and all the reported cases were associated with a systemic vascular or cerebral disease.

In Gass series, type 3 was described in 7 of 140 (5%) patients [2]. Yannuzi simplified this classification in 2006, and called type 1 as aneurysmal telangiectasia and type 2 as perifoveal telangiectasia. Features of the third type were not observed, so it has been omitted due to its rarity [3]. Maruko et al., in a case series of macular telangiectasia in Japanese population including 27 patients, reported four eyes of two patients (7.4%) with MacTel type 3 [4].

Here, we report an otherwise healthy woman whose clinical picture is mostly compatible with bilateral idiopathic occlusive macular telangiectasia.

Case presentation

A 58-year-old Iranian woman presented with gradual decline in vision in both eyes since adolescence that had worsened recently. Her past medical history was unremarkable and she neither smoked nor drank alcohol, nor she did not take any medication except intravitreal injection of anti-VEGF in her left eye 2 years previously. At presentation, her vital signs were stable (pulse rate 80 beats/minute, blood pressure: 115/60 mmHg, temperature: 36.9 °C), and baseline best-corrected visual acuity (BCVA) was 3/10 in both eyes. Anterior segment examination using slit-lamp biomicroscopy was unremarkable, and intraocular pressure was within normal limits. Dilated fundus examination revealed parafoveal telangiectatic vessels with capillary dilatation, as well as barely visible sclerotic vessels temporal to the macula, in both eyes. There was also dense circinate exudation and edema in the macula of the right eye. In the left eye, irregular perifoveal graying discoloration was evident (Fig. 1). Optical coherence tomography (OCT) of the macula in the right eye demonstrated aneurysms of various sizes located within inner retinal layers as well as exudation and retinal thickening. Retina in the macular area of the left eye was atrophic with disorganization of retina inner layers (DRIL). Of note, despite extensive capillary dropout, the architecture of the photoreceptors remained intact (Fig. 2a, c).

Fig. 1
figure 1

Color fundus photographs of the right (a) and left (b) eye demonstrate parafoveal telangiectatic vessels and round red lesions representing microaneurysms as well as occluded sclerotic vessels (black arrows) in both eyes. Macular edema and circinate exudation are evident in the right eye (a)

Fig. 2
figure 2

Macula OCT of the right eye (a) shows various-sized aneurysms within inner retinal layers, exudation, and retinal thickening in the form of CME. Macula OCT of the left eye (c) shows an atrophic thin retina with poorly defined layers. En face 3 × 3 mm OCTA in b and d demonstrates aneurysms and telangiectatic capillaries in deep and superficial capillary plexuses with sparse and distorted vessels in superficial plexus (left frames in b, d) and diffuse vascular rarefaction and dropout, telangiectatic vessels, and FAZ enlargement in deep capillary plexus (right frames in b, d), more prominent in the right eye (b). After 24 months, anti-VEGF injection in her right eye showed no improvement (e) and the left eye remained unchanged, without anti-VEGF injection (f)

The 3 × 3 mm en face OCT angiography (OCTA) visualized aneurysms and telangiectasia in capillaries of deep and superficial capillary plexuses of the retina. In addition, vessels in the superficial plexus were sparse, distorted, and elongated with decreased density. More affected, deep capillary plexus showed diffuse rarefaction, telangiectasia, blunting of capillaries, and enlargement of the foveal avascular zone (FAZ) and perifoveal capillary loss, which were more prominent in the right eye (Fig. 2b, d).

Right eye fundus autofluorescence imaging showed florid-like hyper-autofluorescence, suggesting CME (Fig. 3a, d). Fluorescein angiography (FA) revealed dilated capillary bed in the parafoveal area, bordering capillary-free zone in both eyes. Also, pooling in the aneurysms and late intraretinal staining in the region of telangiectasia occurred, being more prominent in the right eye. The FAZ was enlarged and regions of capillary dropout were observed in the perifoveal area of both eyes (Fig. 3b, c, e, f).

Fig. 3
figure 3

Fundus autofluorescence of right (a) and left (d) eye demonstrate florid-like hyper-autofluorescence in the right eye (a), suggesting CME. Fluorescein angiography of the right (b, c) and left (e, f) eye visualized numerous aneurysms that pool fluorescein, telangiectasia in the parafoveal area, enlarged FAZ, as well as small area with perifoveal capillary dropout, more prominent in the right eye (b, c)

We requested a neurological consultation for our patient to search for neurological impairment such as stroke, vasculitis, or white matter lesion. The result was as follows: The patient is alert and oriented with normal speech. Sensory or motor deficit is absent. Muscle strength is 5/5 bilaterally. Deep tendon reflexes are brisk, 2+, and symmetric in limbs. Babinski reflex is negative, and examination cranial nerves reveals them to be intact. Cerebellar tests such as finger to nose and heel to shin is smooth without dysmetria. Coordination is intact measured by walk toe–heel. Gait is steady with normal base. According to the possible chances of associated neurological deficits, brain magnetic resonance imaging (MRI) was ordered and came back as unremarkable.

Extensive systemic workup was also undertaken to search for an underlying etiology. Laboratory investigations including coagulation tests, blood chemistries, renal and liver function tests, urinalysis, and microbiologic studies showed no abnormalities. The results are as follows:

Complete blood count: RBC: 5.22 (× 106/microL), Hct: 38.2%, HGB: 12.2 g/dL, WBC: 7.8 (× 103/microL), Plt: 290 (× 103/microL); liver function test: SGPT: 21 (U/L), SGOT: 30 (U/L) ALP: 300 (U/L); renal function test: BUN: 8 mg/dL Cr: 0.95 mg/dL; urinalysis: color: yellow, clear with negative protein, ketone, bilirubin and nitrates, pH: 6.0, specific gravity: 1.015; FBS: 78 mg/dL. Serology testing result was as follows: TB (IGRA), Toxoplasma IgG and IgM (0.1 CLIA), HIV, VDRL, RPR as well as FTA-ABS, and CRP were all negative. Anti dsDNA (10 IU/ml), ANA, anti-neutrophilic cytoplasmic antibody (c-ANCA) and p-ANCA, lupus anticoagulant (0.95) and anticardiolipin (0.1 AEU), and serum complement (95 mg/dL) were all negative. Serum protein electrophoresis, serum cryoglobulin (115 mg/dL) was within normal range. ESR (30 mm/hr), Ca: 9.6 mg/dL, P: 4.1 mg/dL, PT: 13 seconds and PTT: 31 seconds were all unremarkable.

We suggested an anti-VEGF injection in her right eye with macular edema. The left eye with atrophic retina remained untreated. Injection of intravitreal bevacizumab was not effective for the right eye, with no improvement. Her last follow-up OCT is illustrated in Fig. 2e, which was taken 2 years after anti-VEGF injection. Informed consent was obtained from the patient to report her condition.

Discussion and conclusions

We report a case of bilateral macular telangiectasia with capillary obliteration in an otherwise healthy middle-aged woman, which was compatible with the diagnosis of MacTel type 3. Although presentation in female sex with bilateral involvement has been reported in 6% of patients with MacTel type 1 [2], the presence of occluded vessels around the macula argues against this diagnosis. Moreover, the area of capillary nonperfusion in our case is more extensive than expected for MacTel type 1. Bilateral ischemic parafoveolar region bordered by occlusive telangiectasia was considered characteristic for MacTel type 3. This subclass of MacTel had been eliminated from the updated classification of MacTel by Yannuzi [3].

All patients reported primarily by Gass as MacTel type 3 had some other systemic conditions such as polycythemia, gouty arthritis, or hypoglycemia, most probably predisposing these patients to capillary obstruction [2, 3]. Hyperreflexia, and central nervous system lesions were also noted in a subset of patients with type 3 MacTel [2, 5]. Maruko, however, published a series in which both patients with type 3 MacTel were female and had bilateral presentation. Visual acuity was good (the worst eye had BCVA of 0.7), despite retinal atrophy in OCT. The only systemic association was controlled hypertension in both patients [4]. Congenital multisystemic disorders may also accompany occlusive telangiectasia. In a genetic disorder called cerebroretinal microangiopathy with calcifications and cysts (CRMCC), characterized by obstruction of small vessels in the brain, retina, and gastrointestinal system, the retinal manifestations resembled MacTel type 3 with telangiectasia, obliteration, and capillary dropout as well as cystoid macular edema in one of the eyes. However, this multisystemic congenital condition is highly symptomatic, which led to early clinical diagnosis [6]. One may hypothesize that, in the absence of systemic disorders, macular pathology may remain unnoticed. Of note, frequent systemic assessment of patients with features of MacTel 3 should be kept in mind to discover any associated systemic condition that may manifest later.

To explain asymmetric retinal involvement and unilateral exudation in cases of MacTel type 3, Gass et al. speculated that deformed capillaries may have sufficient function for many years until gradual endothelial injury decompensated vascular drainage function and subsequent serous exudation, and retinal edema appears in the form of CME. The study also noted that the main reason for visual loss in patients with MacTel type 3 is ischemia of macula and subsequent atrophy of juxtafoveolar retina, rather than exudation. However, he reported a relatively good visual acuity in his series despite having an enlarged FAZ [1]. Considering the progressive nature of the course of capillary obstruction and longstanding edema in the macular area, a subsequent gradual decrease in vision due to ellipsoid zone disruption is expected [1, 4, 7, 8].

We observed macular thinning and DRIL in OCT B-scans in the absence of exudation in the left eye, which can be attributed to occlusive vasculopathy and ischemia in the macular area. The DRIL length has been demonstrated to correlate positively with FAZ size in retinal vascular disease [9]. In our patient, OCTA also confirmed juxtafoveolar capillary dropout that affected both the superficial and deep capillary plexuses. Nevertheless, the architecture of the photoreceptors remained intact. Likewise, Seraly et al. also reported a case with extensive macular capillary dropout with intact ellipsoid zone in a patient with type 3 MacTel [5].

There is no clear evidence in the literature on the role of anti-VEGF in MacTel cases [10, 11]. In accordance with this, we did not observe resorption of macular edema with anti-VEGF injection.

We present a case with features mostly compatible with the diagnosis of MacTel type 3. In 36 months of follow-up, no systemic association could be found. We hope this case sheds more light on the heterogeneity of this disease.

Availability of data and materials

The documents used and reported in the current study are available for consultation upon reasonable request.



Optical coherence tomography


Optical coherence tomography angiography


Idiopathic macular telangiectasia


Macular telangiectasia


Cystoid macular edema


Vascular endothelial growth factor


Disorganization of retina inner layers


Foveal avascular zone


Fluorescein angiography


Best-corrected visual acuity


Cerebroretinal microangiopathy with calcifications and cysts


  1. Gass D, Oyakawa RT. Idiopathic juxtafoveolar retinal telangiectasis. Arch Ophthalmol. 1982;100(5):769–80.

    Article  CAS  Google Scholar 

  2. Gass JDM, Blodi BA. Idiopathic juxtafoveolar retinal telangiectasis: update of classification and follow-up study. Ophthalmology. 1993;100(10):1536–46.

    Article  CAS  Google Scholar 

  3. Yannuzzi LA, Bardal AMC, Freund KB, Chen KJ, Eandi CM, Blodi B. Idiopathic macular telangiectasia. Arch Ophthalmol. 2006;124:450–60.

    Article  Google Scholar 

  4. Maruko I, Iida T, Sugano Y, Ojima A, Oyamada H, Sekiryu T. Demographic features of idiopathic macular telangiectasia in Japanese patients. Jpn J Ophthalmol. 2012;56(2):152–8.

    Article  Google Scholar 

  5. Seraly MP, Badawi KH, Gupta SK, Jabbour NM, Ellis B, Leys M. A rare case of occlusive juxtafoveolar retinal telangiectasias associated with lesions of the central nervous system: a cerebroretinal vasculopathy like phenotype without mutations in the TREX1 gene. Am J Ophthalmol Case Rep. 2020;20: 100985.

    Article  Google Scholar 

  6. Choudhry N, Orlin A, Bilaniuk L, Maguire AM. Cerebroretinal microangiopathy with occlusive telangiectasia and multisytemic manifestations. J AAPOS. 2011;15(5):502–3.

    Article  Google Scholar 

  7. Takayama K, Ooto S, Tamura H, Yamashiro K, Otani A, Tsujikawa A, et al. Retinal structural alterations and macular sensitivity in idiopathic macular telangiectasia type 1. Retina. 2012;32(9):1973–80.

    Article  Google Scholar 

  8. Kim SH, Oh J, Ahn SE, Park CY, Oh JH. Demographic features of idiopathic macular telangiectasia in Korean patients. Korean J Ophthalmol. 2015;29(3):155–9.

    Article  Google Scholar 

  9. Balaratnasingam C, Inoue M, Ahn S, McCann J, Dhrami-Gavazi E, Yannuzzi LA, Freund KB. Visual acuity is correlated with the area of the foveal avascular zone in diabetic retinopathy and retinal vein occlusion. Ophthalmology. 2016;123(11):2352–67.

    Article  Google Scholar 

  10. Lorusso M, Zito R, Nikolopoulou E, Micelli Ferrari L, Cicinelli MV, Querques G, et al. progression of retinal ischemia in a case of macular telangiectasia type 1 after ranibizumab injection: optical coherence tomography angiography findings. Retin Cases Brief Rep. 2020;14(4):372–6.

    PubMed  Google Scholar 

  11. Gamulescu MA, Walter A, Sachs H, Helbig H. Bevacizumab in the treatment of idiopathic macular telangiectasia. Graefe’s Arch Clin Exp Ophthalmol. 2008;246(8):1189–93.

    Article  CAS  Google Scholar 

Download references





Author information

Authors and Affiliations



Data acquisition (AA, AM, MS); data interpretation (NE, HR, AM); major contributor in writing the manuscript (MS); critical revision of the manuscript (NE, HR); supervision (NE); All authors read and approved the final manuscript.

Corresponding author

Correspondence to Nazanin Ebrahimiadib.

Ethics declarations

Ethics approval and consent to participate

Written informed consent was obtained from the patient.

Consent for publication

Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Samadi, M., Azarkish, A., Riazi-Esfahani, H. et al. Macular telangiectasia with bilateral obliterated capillaries: a case report. J Med Case Reports 16, 372 (2022).

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI:


  • Macular telangiectasia
  • MacTel type 3
  • MacTel classification